Your browser doesn't support javascript.
loading
Eculizumab in Posttransplant TMA: Unproven Benefit: A Response to Maritati et al.: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.
Bouwmeester, Romy N; Wetzels, Jack F M; van de Kar, Nicole C A J.
Affiliation
  • Bouwmeester RN; Radboud University Medical Center, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Nijmegen, The Netherlands.
  • Wetzels JFM; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The Netherlands.
  • van de Kar NCAJ; Radboud University Medical Center, Amalia Children's Hospital, Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Nijmegen, The Netherlands.
Kidney Int Rep ; 9(6): 1929, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38899173
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Int Rep / Kidney international reports Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Kidney Int Rep / Kidney international reports Year: 2024 Document type: Article Affiliation country: Country of publication: